Squarepoint’s Omega Protein OME Stock Holding History

Squarepoint’s Portfolio OME Stock Details OME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-10,195	Closed	-$255K	–	2154
2016 Q4	$255K	Buy	+10,195	New	+$241K	0.01%	1257

Other funds holding OME

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

JIR

James Investment Research Alpha, Ohio $891M AUM 30.4% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Squarepoint's OME Position: Q1 2017 in Review

Squarepoint sold out of Omega Protein (OME) in Q1 2017, closing a stake of 10,195 shares — an estimated $255K sold.

Squarepoint first reported a position in OME in Q4 2016 and held it in 1 quarter. The position peaked at $255K in Q4 2016. 144 funds tracked by Wall St. Rank hold OME as of Q1 2017.

Squarepoint reported no remaining Omega Protein position as of Q1 2017 after selling out during the quarter.
Squarepoint sold 10,195 Omega Protein shares in Q1 2017, an estimated $255K.
Squarepoint first reported a position in Omega Protein in Q4 2016 and held it in 1 quarter.
Squarepoint's Omega Protein position peaked at $255K in Q4 2016.
144 funds tracked by Wall St. Rank held Omega Protein as of Q1 2017.

Based on Squarepoint's 13F filing for Q1 2017, filed 15 May 2017.